Shri Ahimsa Naturals Ltd (SHRIAHIMSA) — shareholding pattern, promoter holding, financials and share price
About Shri Ahimsa Naturals Ltd (SHRIAHIMSA)
Shri Ahimsa Naturals Ltd operates in the Specialty Chemicals industry, within the Chemicals sector. It trades on the NSE as SHRIAHIMSA and on the BSE under scrip code 79673. Its ISIN is INE0DM401012.
Incorporated in 1990, Shri Ahimsa Naturals Limited extracts and manufactures Caffeine Anhydrous, Green Coffee Bean Extracts, and Crude Caffeine, also trading other herbal extracts. [1]
Ahimsa Naturals Limited specializes in the extraction and manufacturing of natural caffeine and other herbal extracts. The company has steadily diversified its product line, including launching Green Coffee Bean Extract in 2017-18 and expanding into herbal extracts by 2021. In 2022, Ahimsa began producing crude caffeine from tea and coffee waste, showcasing its commitment to sustainable practices. The company is preparing for an IPO, indicating strategic growth ambitions and plans to enhance its market presence.
Listed peers in Specialty Chemicals: Gem Aromatics Ltd, Sunshield Chemicals Ltd, Sudarshan Pharma Industries Ltd, Fairchem Organics Ltd, Indo Amines Ltd, Amal Ltd.
Valuation & Returns
10 Jul 2026At ₹401 a share on 10 Jul 2026, Shri Ahimsa Naturals Ltd (SHRIAHIMSA) was valued at a price-to-earnings ratio of 32.28x against an industry P/E of 45.11x and a price-to-book of 4.86x on a book value of ₹82.51 per share. Solomo computes return on equity of 15.06% and return on capital employed of 18.76% from filed results.
- P/E
- 32.28x
- Industry P/E
- 45.11x
- P/B
- 4.86x
- EPS (TTM)
- ₹11.6
- Book value / share
- ₹82.51
- ROE
- 15.06%
- ROCE
- 18.76%
- ROA
- 13.33%
- Debt / equity
- 0.1x
- Dividend yield
- 0%
- EBITDA margin
- 33.98%
- 52-week range
- ₹151 – ₹455
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Shri Ahimsa Naturals Ltd (SHRIAHIMSA) reported revenue of ₹123 crore, net profit of ₹29 crore and earnings per share of ₹12.42. That compares with revenue of ₹96 crore and net profit of ₹22 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹63 crore and net profit ₹15 crore (consolidated).
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue (₹ cr) | 104 | 78 | 96 | 123 |
| Net profit (₹ cr) | 38 | 19 | 22 | 29 |
| EPS (₹) | 72.99 | 10.19 | 9.39 | 12.42 |
| Measure | 5Y | 3Y | 1Y |
|---|---|---|---|
| Sales growth | 34.70% | 18.18% | 22.86% |
| Profit growth | 78.81% | 24.93% | 17.11% |
| Stock price CAGR | - | - | 131% |
Ownership Summary
Mar 2026As of Mar 2026, promoters hold 68.4% of Shri Ahimsa Naturals Ltd (SHRIAHIMSA). Market capitalisation was ₹940 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2025.
Largest disclosed public shareholders in Mar 2026: BHARAT VENTURE OPPORTUNITIES FUND 1.8%, KHOOBSURAT LIMITED 1.71%, FOUNDERS COLLECTIVE FUND 1.7%, WEALTHWAVE CAPITAL TRUST-WEALTHWAVE CAPITAL FUND 1.36%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Mar 2026 | 68.4% | - | - | - | - |
| Sep 2025 | 68.68% | - | - | - | - |
| Mar 2025 | 68.68% | - | - | - | - |